Sensitivity, specificity, and AUC benchmarks — including head-to-head comparisons with general dentists and specialists. The numbers are encouraging, but the caveats matter too.
What this article covers
A structured breakdown of how AI performance is measured in dental radiology — sensitivity, specificity, AUC curves, and what clinical studies actually show when AI goes head-to-head with dentists on OPG and periapical X-ray interpretation.
When a dentist misses an early periapical lesion on a radiograph, the patient usually comes back six months later with an abscess. When AI does the same — at scale, across hundreds of patients — the problem compounds quietly until it isn't quiet anymore.
So accuracy isn't just a technical benchmark. It's a clinical safety question. And the answer, it turns out, is complicated in useful ways.
How AI accuracy is measured in radiology
Three numbers dominate the literature: sensitivity (how often the AI catches a real finding), specificity (how often it correctly rules out a finding that isn't there), and AUC — the area under the ROC curve, which tells you how well the model discriminates across all possible thresholds. AUC of 1.0 is perfect; 0.5 is a coin flip.
The honest answer is that AI performance varies considerably by task. Caries detection on bitewing X-rays looks different from periapical pathology detection on OPGs. The numbers below represent the best-quality published studies as of early 2025 — mostly prospective validation datasets, not the training sets the models learned on.
91.3%
Avg. Sensitivity
AI — Caries Detection
Schwendicke et al, JDR 2021
89.7%
Avg. Specificity
AI — Caries Detection
Schwendicke et al, JDR 2021
0.94
AUC
Periapical Lesion Detection
Orhan et al, Dentomaxillofac 2020
These are strong numbers. For context, a general dentist's sensitivity for proximal caries on bitewing X-rays typically runs between 70–80%, and specificity between 75–85%. The AI systems tested in peer-reviewed settings consistently hit the upper end of those ranges — and several exceed them.
The more interesting finding — and this shows up repeatedly — is that the gap between AI and specialists is much smaller than the gap between AI and general dentists. An oral radiologist reviewing the same X-rays will often perform similarly to the AI. Which raises a question worth sitting with: should the benchmark be the generalist or the specialist?
How to read these numbers
Methodology noteSensitivity
True positive rate. High sensitivity = AI rarely misses a real finding. The cost of a low number is false negatives — missed pathology.
Specificity
True negative rate. High specificity = AI rarely flags healthy tissue as diseased. The cost of a low number is false positives — unnecessary treatment.
AUC
Aggregate discriminative ability across all thresholds. Useful for comparing models independent of the threshold chosen. AUC ≥ 0.90 is generally considered strong for clinical tasks.
PPV/NPV
Positive and negative predictive values — how often a positive or negative AI result actually holds. These change with disease prevalence, which is why they're often omitted from lab studies but matter more in the clinic.
Several studies have run AI systems and dentists through the same radiograph datasets under controlled conditions. The picture that emerges isn't “AI wins” — it's more nuanced than that. Task, training, and experience level all shift the outcome significantly.
| Task | AI Sensitivity | General Dentist | Specialist | AI AUC |
|---|---|---|---|---|
| Proximal caries (bitewing) | 91% | 74% | 88% | 0.95 |
| Periapical lesions (periapical X-ray) | 89% | 72% | 90% | 0.94 |
| Bone level assessment (OPG) | 84% | 79% | 91% | 0.88 |
| Calculus detection | 87% | 68% | 82% | 0.91 |
| Root fractures (CBCT) | 76% | 71% | 93% | 0.82 |
Sources: aggregate from Schwendicke 2021, Orhan 2020, Bayrakdar 2021, Vinayahalingam 2019. Values represent mean across studies; individual results vary by model and dataset.
Two patterns are worth flagging. First, AI consistently outperforms general dentists on the common, high-volume tasks — proximal caries and periapical lesions. These are exactly the cases where radiology workload is heaviest in a typical clinic. Second, AI struggles more on tasks requiring 3D reasoning or complex structural interpretation, where specialist advantage remains significant.
AI-assisted vs. AI-autonomous: an important distinction
Most published studies test AI in detection mode — flagging findings for a human to review. Studies that test AI as a pure autonomous reader (no human in the loop) show lower effective accuracy in practice. The performance numbers above assume human oversight of AI outputs, which is how responsible clinical deployment works.
Performance in controlled datasets and performance in a working clinic aren't the same thing. The gap between those two contexts is where a lot of AI radiology tools quietly fall apart — and it's what separates a validated clinical tool from a research prototype dressed up for enterprise sales.
Training data bias. Most commercial AI systems were trained predominantly on X-rays from specific geographies and machine types. An AI trained on digital sensors from North American clinics may underperform on phosphor plate images from South Asian markets — where patient anatomy, disease prevalence, and equipment profiles differ. Independent validation on local datasets matters.
Image quality dependency. AI sensitivity drops noticeably on low-quality radiographs. Poor angulation, overexposure, cone cutting — all reduce AI performance in ways that don't get reported clearly in studies that only include high-quality training images. Real-world clinic X-rays have a lot more variation.
The spectrum problem. Most studies test AI on radiographs with confirmed pathology (ground truth verified histologically or by expert consensus). In a real clinic, the AI sees ambiguous, early-stage, and borderline cases far more often. Sensitivity on clear-cut lesions doesn't tell you how the model handles the grey zone.
Regulatory status varies. AI tools validated in published studies aren't automatically cleared for clinical use in every market. In India, FDA-cleared AI diagnostic tools are beginning to go through CDSCO pathways. Regulatory approval and published accuracy aren't the same thing — a tool can have strong AUC and still lack clearance for clinical decision support.
Overdiagnosis risk. High sensitivity is generally a good thing — but not when it comes at the cost of specificity. AI systems tuned for high recall can generate false positives that lead to unnecessary treatment. A patient who gets a filling they don't need is also a clinical failure.
The short version: AI is a second reader, not a replacement. The strongest evidence supports using AI to reduce missed findings on high-volume radiographic screening tasks — particularly proximal caries and periapical pathology — while keeping clinical judgment firmly in the loop for treatment decisions.
The more nuanced version: AI performs best when it's integrated into the diagnostic workflow at the right point. Using it as a post-hoc check (“did the AI flag anything I didn't see?”) tends to produce different — and in some studies, worse — outcomes than using it as a prospective screening tool before the dentist reviews the image.
The AI + clinician combination outperforms either alone
Several studies have tested AI-assisted reading versus AI-alone and clinician-alone conditions. The consistent finding: when a dentist reviews AI findings alongside the original image, combined sensitivity and specificity beats both single-reader conditions. AI catches what the dentist missed; the dentist filters false positives the AI generated.
Not in current clinical practice, and the evidence doesn't support deploying it that way. AI radiology tools are validated as decision support — meaning they're designed to assist a licensed clinician, not replace the diagnostic process. The combination of AI detection and clinician review consistently outperforms either alone. Autonomy might be a reasonable goal in the future for specific, narrow tasks (screening low-risk populations for obvious pathology), but that's not where the science or the regulations are right now.
Medecro AI X-Ray Analyzer
Medecro's AI X-Ray Analyzer provides OPG and periapical analysis with confidence scoring, finding annotations, and one-click override — fully integrated into your existing clinic workflow. No separate login, no standalone app.
Book a Demo — See It LiveSources & references